Author

Zainul S. Hasanali

Indiana University IndianapolisORCID 0000-0002-9150-089XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Approach:biophysical modeling· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Dan T. VogliD· 2 shared David AllmaniD· 2 shared Adam D. CoheniD· 1 shared Adam Justin WaxmaniD· 1 shared Alfred L. GarfalliD· 1 shared Andrei Thomas‐TikhonenkoiD· 1 shared Annette CastroiD· 1 shared Cara Cipriano· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Dan T. VoglORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mast Cells Enhance Myeloma Engraftment and Promote Bone Destruction in the NSG-hIL6 Patient Derived Xenograft Model

Zainul S. Hasanali, Alfred L. Garfall, Dan T. Vogl, Adam D. Cohen, Adam Justin Waxman, Sandra P. Susanibar-Adaniya, Shivani Kapur, Edward Stadtmauer, Cara Cipriano, Kristy Weber, David Allman

This study shows mast cells enhance myeloma engraftment and promote bone destruction in the NSG-hIL6 xenograft model by secreting factors that improve myeloma cell survival.

bioRxiv · May 18, 2026 · PreprintCancer Biology

The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target

Zhiwei Ang, Annette Castro, Luca Paruzzo, Carolin Schimdt, Zainul S. Hasanali, Katharina E. Hayer, Federico Stella, Samantha S. Soldan, Manuel Torres-Diz, Christopher Kwok, Patricia King Sainos, Kayla W. Ji, Patrick J. Krohl, Justyn Fine, Priyanka D. Sehgal, , Andrei Thomas‐Tikhonenko

The paper identifies P2RX5 as a new B-cell surface marker and multi-lineage immunotherapy target, showing its expression in B-cell malignancies and T-cell leukemia, and demonstrating the efficacy of P2RX5-directed therapies.

bioRxiv · Jan 26, 2026 · PreprintCancer Biology